Abstract
Individuals with HIV/hepatitis C virus (HCV) coinfection experience accelerated progression to severe liver disease. Although these patients may benefit from prompt HCV treatment, few receive it. To determine why, researchers reviewed data from 845 HIV/HCV-coinfected patients who had received HIV care at a Baltimore clinic at least twice in 2 consecutive years from mid-1998 through 2003 (median age, 40; 63% men; 85% African American). A total of 277 patients (33%) were referred for HCV care in the on-site viral hepatitis clinic, but only 185 completed at least one visit there. Of these 185 patients, 125 (68%) completed an evaluation …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
